Latin American Real-world Study in Acute Leukemia
NCT05166135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 589
Last updated 2025-03-25
Summary
The objective of the study is to describe the current epidemiology, treatment patterns, outcomes and healthcare resource use of adult patients diagnosed with relapsed/refractory (R/R) B-cell ALL and de novo AML in 4 Latin American countries.
Conditions
- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-10
- Primary Completion
- 2022-11-15
- Completion
- 2022-11-15
Countries
- Argentina
- Brazil
- Chile
- Colombia
Study Locations
More Related Trials
-
Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL
NCT03502876 ·Status: COMPLETED
-
First Report, Five Years Experience of the Acute Leukemia Work Group
NCT02990104 ·Status: UNKNOWN
-
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
NCT05893836 ·Status: COMPLETED
-
A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers
NCT05541224 ·Status: COMPLETED
-
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
NCT01408160 ·Status: TERMINATED ·Phase: PHASE1
-
Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia
NCT02353143 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia
NCT00510939 ·Status: UNKNOWN ·Phase: PHASE2
-
A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)
NCT05460533 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL
NCT03123887 ·Status: COMPLETED
-
ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AML
NCT06512610 ·Status: NOT_YET_RECRUITING
-
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
NCT05086315 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France
NCT06565975 ·Status: COMPLETED
-
Study of Efficacy and Safety of CTL019 in Adult ALL Patients
NCT02167360 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
NCT05100303 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
NCT02783651 ·Status: COMPLETED
-
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
NCT01244750 ·Status: COMPLETED
-
Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence
NCT05310591 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
NCT04887259 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Palbociclib in MLL-rearranged Acute Leukemias
NCT02310243 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings
NCT05590702 ·Status: ACTIVE_NOT_RECRUITING
-
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
NCT01540578 ·Status: COMPLETED
-
Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.
NCT04311060 ·Status: NOT_YET_RECRUITING
-
Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
NCT06034561 ·Status: RECRUITING ·Phase: PHASE2
-
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2
NCT04070807 ·Status: UNKNOWN
-
Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia
NCT00336206 ·Status: UNKNOWN ·Phase: NA